MannKind | MNKD - Выручка от реализации





Продажи Изменить Дата
Adma Biologics USD 114.5M 24.66M 2026-03
BioCryst Pharmaceuticals USD 218.25M 188.3M 2026-06
Eli Lilly USD 22.97B 3.17B 2026-06
Halozyme Therapeutics USD 481M 104M 2026-06
Insmed USD 425.49M 119.53M 2026-06
Karyopharm Therapeutics USD 35.07M 987K 2026-03
MacroGenics USD 20.8M 20.43M 2026-03
MannKind USD 109.37M 19.17M 2026-06
Merck USD 16.6B 310M 2026-06
Minerva Neurosciences USD 0 0 2024-09
Novavax USD 147.14M 76.69M 2025-12
Novo Nordisk DKK 12.13B 84.69B 2026-06
Pfizer USD 15.03B 530M 2026-06
Sanofi EUR 11.95B 710M 2026-06
Xencor USD 51.22M 46.71M 2026-06